
BoltzMol-1: Our first small-molecule hit-discovery pipeline leveraging an optimized affinity model and a new suite of ADMET models. We tested BoltzMol on 10 very challenging OOD targets and we got confirmed hits on 6, while only testing a few compounds per target (28–51).








